Health Trials

A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patients With Early Breast Cancer Eligible for EndoPredict® Testing

ConditionsBreast CancerBreast Adenocarcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNational and Kapodistrian University of Athens

About this trial

The study is planned to observe and document the therapeutic decision-making process, treatment protocols, and clinical outcomes in patients with luminal breast cancer, whether they have undergone EndoPredict® testing or not

Eligibility criteria

Qualifiers

Age ≥ 18 years old.

Histological diagnosis of invasive breast cancer.

T1-T3 tumor size.

0-3 positive axillary lymph nodes.

Disqualifiers

History of another primary malignancy within the last 5 years, except for resected non-melanoma skin cancer.

Pre-operative chemotherapy administered.

Subject without signed and dated informed consent form.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

2,000 Participants
are grouped into 1 trial group

Locations

13
"Elena Venizelou" General Hospital, Department of Surgery Athens Greece
"Prolipsis" Center, Breast Unit Athens Greece
Henry Dunant Hospital Center, 3rd Breast Surgical Department Athens Greece
Laiko Hospital, National and Kapodistrian University of Athens, Medical School Athens Greece

Sponsors and collaborators

National and Kapodistrian University of Athens

Lead sponsor

Source ClinicalTrials.gov